<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34253796</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex.</ArticleTitle><Pagination><StartPage>14283</StartPage><MedlinePgn>14283</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14283</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-93742-3</ELocationID><Abstract><AbstractText>There is increasing evidence that endogenous retroviruses (ERVs) play a significant role in central nervous system diseases, including amyotrophic lateral sclerosis (ALS). Studies of ALS have consistently identified retroviral enzyme reverse transcriptase activity in patients. Evidence indicates that ERVs are the cause of reverse transcriptase activity in ALS, but it is currently unclear whether this is due to a specific ERV locus or a family of ERVs. We employed a combination of bioinformatic methods to identify whether specific ERVs or ERV families are associated with ALS. Using the largest post-mortem RNA-sequence datasets available we selectively identified ERVs that closely resembled full-length proviruses. In the discovery dataset there was one ERV locus (HML6_3p21.31c) that showed significant increased expression in post-mortem motor cortex tissue after multiple-testing correction. Using six replication post-mortem datasets we found HML6_3p21.31c was consistently upregulated in ALS in motor cortex and cerebellum tissue. In addition, HML6_3p21.31c showed significant co-expression with cytokine binding and genes involved in EBV, HTLV-1 and HIV type-1 infections. There were no significant differences in ERV family expression between ALS and controls. Our results support the hypothesis that specific ERV loci are involved in ALS pathology.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Ashley R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK. ashley.r.jones@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adey</LastName><ForeName>Brett N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowles</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatunov</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troakes</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MRC London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garson</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Infection and Immunity, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>Adele L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of Westminster, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L016397/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>JONES/OCT15/958-799</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2022 Aug 19;12(1):14171</RefSource><PMID Version="1">35986057</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020077" MajorTopicYN="N">Endogenous Retroviruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006678" MajorTopicYN="N">HIV</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011533" MajorTopicYN="N">Proviruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="N">RNA-Seq</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Ammar Al-Chalabi reports grants from Motor Neurone Disease Association, grants from Betty Messenger Foundation, grants from Anonymous Family Trust, grants from Joint Programme on Neurodegeneration via MRC, grants from NIHR during the conduct of the study, other from Mitsubishi Tanabe Pharma, other from OrionPharma, other from Cytokinetics, other from Chronos Therapeutics, outside the submitted work. Ashley R Jones, Alfredo Iacoangeli, Brett N Adey, Harry Bowles, Aleksey Shatunov, Claire Troakes, Jeremy A Garson, and Adele L McCormick report no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34253796</ArticleId><ArticleId IdType="pmc">PMC8275748</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-93742-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-93742-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Majounie E, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Payer LM, Burns KH. Transposable elements in human genetic disease. Nat. Rev. Genet. 2019;20:760&#x2013;772. doi: 10.1038/s41576-019-0165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0165-8</ArticleId><ArticleId IdType="pubmed">31515540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho SS, Urban AE, Mills RE. Structural variation in the sequencing era. Nat. Rev. Genet. 2020;21:171&#x2013;189. doi: 10.1038/s41576-019-0180-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0180-9</ArticleId><ArticleId IdType="pmc">PMC7402362</ArticleId><ArticleId IdType="pubmed">31729472</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage AL, et al. Retrotransposons in the development and progression of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2018;90:284. doi: 10.1136/jnnp-2018-319210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319210</ArticleId><ArticleId IdType="pmc">PMC6518469</ArticleId><ArticleId IdType="pubmed">30305322</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortijo S, et al. Mapping the epigenetic basis of complex traits. Science (80-.) 2014;343:1145&#x2013;1148. doi: 10.1126/science.1248127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1248127</ArticleId><ArticleId IdType="pubmed">24505129</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I, et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:2220&#x2013;2231. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ry P, et al. Human endogenous retroviruses in neurological diseases. Trends Mol. Med. 2018;24:379&#x2013;394. doi: 10.1016/j.molmed.2018.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.02.007</ArticleId><ArticleId IdType="pmc">PMC7185488</ArticleId><ArticleId IdType="pubmed">29551251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Ostrow LW, Gale Hammell M. Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease. Mob. DNA. 2019;10:1&#x2013;4. doi: 10.1186/s13100-019-0176-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-019-0176-1</ArticleId><ArticleId IdType="pmc">PMC6659213</ArticleId><ArticleId IdType="pubmed">31372185</ArticleId></ArticleIdList></Reference><Reference><Citation>Benachenhou F, Blikstad V, Blomberg J. The phylogeny of orthoretroviral long terminal repeats (LTRs) Gene. 2009;448:134&#x2013;138. doi: 10.1016/j.gene.2009.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2009.07.002</ArticleId><ArticleId IdType="pubmed">19595747</ArticleId></ArticleIdList></Reference><Reference><Citation>Benachenhou F, et al. Conserved structure and inferred evolutionary history of long terminal repeats (LTRs) Mob DNA. 2013;4:5. doi: 10.1186/1759-8753-4-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1759-8753-4-5</ArticleId><ArticleId IdType="pmc">PMC3601003</ArticleId><ArticleId IdType="pubmed">23369192</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H, et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J. Neurovirol. 2005;11:23&#x2013;33. doi: 10.1080/13550280590901741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280590901741</ArticleId><ArticleId IdType="pubmed">15804956</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult. Scler. J. 2012;18:1721&#x2013;1736. doi: 10.1177/1352458512441381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458512441381</ArticleId><ArticleId IdType="pmc">PMC3573672</ArticleId><ArticleId IdType="pubmed">22457345</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Horssen J, Van Der Pol S, Nijland P, Amor S, Perron H. Human endogenous retrovirus W in brain lesions: rationale for targeted therapy in multiple sclerosis. Mult. Scler. Relat. Disord. 2016;8:11&#x2013;18. doi: 10.1016/j.msard.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2016.04.006</ArticleId><ArticleId IdType="pubmed">27456869</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, et al. Tau activates transposable elements in Alzheimer&#x2019;s disease. Cell Rep. 2018;23:2874&#x2013;2880. doi: 10.1016/j.celrep.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.05.004</ArticleId><ArticleId IdType="pmc">PMC6181645</ArticleId><ArticleId IdType="pubmed">29874575</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasova MS, et al. Quantitative analysis of L1-retrotransposons in Alzheimer&#x2019;s disease and aging. Biochemistry. 2017;82:962&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pubmed">28941465</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson H, et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001;98:4634&#x2013;4639. doi: 10.1073/pnas.061021998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.061021998</ArticleId><ArticleId IdType="pmc">PMC31886</ArticleId><ArticleId IdType="pubmed">11296294</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, et al. Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia. Genes Brain Behav. 2008;7:103&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">17559415</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte RRR, et al. Schizophrenia risk from locus-specific human endogenous retroviruses. bioRxiv. 2019 doi: 10.1101/798017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/798017</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele AJ, et al. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005;64:454&#x2013;458. doi: 10.1212/01.WNL.0000150899.76130.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000150899.76130.71</ArticleId><ArticleId IdType="pubmed">15699374</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan DJL, et al. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology. 2007;68:1944&#x2013;1946. doi: 10.1212/01.wnl.0000263188.77797.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000263188.77797.99</ArticleId><ArticleId IdType="pubmed">17536052</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick AL, Brown RH, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008;70:278&#x2013;283. doi: 10.1212/01.wnl.0000297552.13219.b4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000297552.13219.b4</ArticleId><ArticleId IdType="pubmed">18209202</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 2011;69:141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 1997;94:7583&#x2013;7588. doi: 10.1073/pnas.94.14.7583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.14.7583</ArticleId><ArticleId IdType="pmc">PMC23865</ArticleId><ArticleId IdType="pubmed">9207135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotgiu S, et al. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult. Scler. 2010;16:1248&#x2013;1251. doi: 10.1177/1352458510376956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458510376956</ArticleId><ArticleId IdType="pubmed">20685761</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis [1] Lancet. 1998;351:33. doi: 10.1016/S0140-6736(98)24001-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)24001-3</ArticleId><ArticleId IdType="pubmed">9433428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001;15:579&#x2013;589. doi: 10.1016/S1074-7613(01)00210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00210-2</ArticleId><ArticleId IdType="pubmed">11672540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruprecht K, et al. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J. Neurovirol. 2006;12:65&#x2013;71. doi: 10.1080/13550280600614973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280600614973</ArticleId><ArticleId IdType="pubmed">16595376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mameli G, et al. Expression and activation by epstein barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS ONE. 2012;7:e44991. doi: 10.1371/journal.pone.0044991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044991</ArticleId><ArticleId IdType="pmc">PMC3459916</ArticleId><ArticleId IdType="pubmed">23028727</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrison KE, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog. 2007;3:1617&#x2013;1627. doi: 10.1371/journal.ppat.0030165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030165</ArticleId><ArticleId IdType="pmc">PMC2065876</ArticleId><ArticleId IdType="pubmed">17997601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon R, et al. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. J. Virol. 2011;85:11526&#x2013;11531. doi: 10.1128/JVI.05418-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05418-11</ArticleId><ArticleId IdType="pmc">PMC3194955</ArticleId><ArticleId IdType="pubmed">21880743</ArticleId></ArticleIdList></Reference><Reference><Citation>SenGupta D, et al. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J. Virol. 2011;85:6977&#x2013;6985. doi: 10.1128/JVI.00179-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00179-11</ArticleId><ArticleId IdType="pmc">PMC3126607</ArticleId><ArticleId IdType="pubmed">21525339</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer&#x2019;s disease brains. J. Med. Virol. 1991;33:224&#x2013;227. doi: 10.1002/jmv.1890330403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890330403</ArticleId><ArticleId IdType="pubmed">1649907</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer&#x2019;s disease. Lancet. 1997;349:241&#x2013;244. doi: 10.1016/S0140-6736(96)10149-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)10149-5</ArticleId><ArticleId IdType="pubmed">9014911</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B, et al. Multiscale analysis of independent Alzheimer&#x2019;s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99:64&#x2013;82.e7. doi: 10.1016/j.neuron.2018.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.023</ArticleId><ArticleId IdType="pmc">PMC6551233</ArticleId><ArticleId IdType="pubmed">29937276</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews WD, et al. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J. Med. Virol. 2000;61:527&#x2013;532. doi: 10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10897073</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl. Med. 2015;7:307ra153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, et al. Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins. Mol. Neurodegener. 2018;13:1&#x2013;25. doi: 10.1186/s13024-018-0275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0275-3</ArticleId><ArticleId IdType="pmc">PMC6091006</ArticleId><ArticleId IdType="pubmed">30068350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson JA, et al. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2019;7:45. doi: 10.1186/s40478-019-0698-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0698-2</ArticleId><ArticleId IdType="pmc">PMC6421708</ArticleId><ArticleId IdType="pubmed">30885274</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L, et al. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13:e1006635. doi: 10.1371/journal.pgen.1006635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M, Ferguson-Parry J, Douville RN. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol. Dis. 2016;94:226&#x2013;236. doi: 10.1016/j.nbd.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.06.017</ArticleId><ArticleId IdType="pubmed">27370226</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie AT, et al. Brain cell type specific gene expression and co-expression network architectures. Sci. Rep. 2018;8:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995803</ArticleId><ArticleId IdType="pubmed">29892006</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifarth W, et al. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J. Virol. 2005;79:341&#x2013;352. doi: 10.1128/JVI.79.1.341-352.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.341-352.2005</ArticleId><ArticleId IdType="pmc">PMC538696</ArticleId><ArticleId IdType="pubmed">15596828</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N, Pisano MP, Scognamiglio S, Pessiu E, Tramontano E. Comprehensive analysis of HERV transcriptome in HIV+ cells: absence of HML2 activation and general downregulation of individual HERV loci. Viruses. 2020;12:481. doi: 10.3390/v12040481.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040481</ArticleId><ArticleId IdType="pmc">PMC7232394</ArticleId><ArticleId IdType="pubmed">32340287</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank O, et al. Variable transcriptional activity of endogenous retroviruses in human breast cancer. J. Virol. 2008;82:1808&#x2013;1818. doi: 10.1128/JVI.02115-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02115-07</ArticleId><ArticleId IdType="pmc">PMC2258715</ArticleId><ArticleId IdType="pubmed">18077721</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonnard S, Jo&#xeb;lle F, Didier C, Thierry B, Coulie PG. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res. 2002;1:5510&#x2013;5516.</Citation><ArticleIdList><ArticleId IdType="pubmed">12359761</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren PJ, et al. Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog. 2013;9:e1003515. doi: 10.1371/journal.ppat.1003515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003515</ArticleId><ArticleId IdType="pmc">PMC3723635</ArticleId><ArticleId IdType="pubmed">23935489</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren PJ, et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc. Natl. Acad. Sci. U.S.A. 2015;112:14658&#x2013;14663. doi: 10.1073/pnas.1514867112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1514867112</ArticleId><ArticleId IdType="pmc">PMC4664299</ArticleId><ArticleId IdType="pubmed">26553974</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367&#x2013;377. doi: 10.1016/S0092-8674(00)80110-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80110-5</ArticleId><ArticleId IdType="pubmed">8756719</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean M, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science (80-.) 1996;273:1856&#x2013;1862. doi: 10.1126/science.273.5283.1856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.273.5283.1856</ArticleId><ArticleId IdType="pubmed">8791590</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhout B, et al. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res. 2002;55:341&#x2013;355. doi: 10.1016/S0166-3542(02)00069-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(02)00069-4</ArticleId><ArticleId IdType="pubmed">12103434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman PM, et al. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N. Engl. J. Med. 1985;313:324&#x2013;325. doi: 10.1056/NEJM198508013130511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198508013130511</ArticleId><ArticleId IdType="pubmed">2989688</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001;57:995&#x2013;1001. doi: 10.1212/WNL.57.6.995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.6.995</ArticleId><ArticleId IdType="pubmed">11571323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J, et al. Safety and tolerability of triumeq in amyotrophic lateral sclerosis: the lighthouse trial. Amyotroph. Lateral Scler. Front. Degener. 2019;20:595&#x2013;604. doi: 10.1080/21678421.2019.1632899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632899</ArticleId><ArticleId IdType="pubmed">31284774</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe4;gelmann J, Lorenzo Bermejo J. A comparative analysis of cell-type adjustment methods for epigenome-wide association studies based on simulated and real data sets. Brief. Bioinform. 2019;20:2055&#x2013;2065. doi: 10.1093/bib/bby068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bby068</ArticleId><ArticleId IdType="pmc">PMC6954449</ArticleId><ArticleId IdType="pubmed">30099476</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018;7:e37754. doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29:1164&#x2013;1177. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatiadis N, Klaus B, Zaugg JB, Huber W. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing. Nat. Methods. 2016;13:577&#x2013;580. doi: 10.1038/nmeth.3885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3885</ArticleId><ArticleId IdType="pmc">PMC4930141</ArticleId><ArticleId IdType="pubmed">27240256</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Commonly used functions by the Jaffe lab jaffelab. http://research.libd.org/jaffelab/.</Citation></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi: 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: Integrating viruses and cellular organisms. Nucl. Acids Res. 2021;49:D545&#x2013;D551. doi: 10.1093/nar/gkaa970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa970</ArticleId><ArticleId IdType="pmc">PMC7779016</ArticleId><ArticleId IdType="pubmed">33125081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947&#x2013;1951. doi: 10.1002/pro.3715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3715</ArticleId><ArticleId IdType="pmc">PMC6798127</ArticleId><ArticleId IdType="pubmed">31441146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 2000;28:27&#x2013;30. doi: 10.1093/nar/28.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLOS Comput. Biol. 2015;11:e1004219. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmont JW, et al. A haplotype map of the human genome. Nature. 2005;437:1299&#x2013;1320. doi: 10.1038/nature04226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04226</ArticleId><ArticleId IdType="pmc">PMC1880871</ArticleId><ArticleId IdType="pubmed">16255080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying J, Oliver TH, Eric P, Molly H. TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics. 2015;31:3593&#x2013;3599. doi: 10.1093/bioinformatics/btv422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv422</ArticleId><ArticleId IdType="pmc">PMC4757950</ArticleId><ArticleId IdType="pubmed">26206304</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>